Log in to save to my catalogue

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn...

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11831650

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients

About this item

Full title

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients

Publisher

England: SAGE Publications

Journal title

International journal of immunopathology and pharmacology, 2025-01, Vol.39, p.3946320251319379

Language

English

Formats

Publication information

Publisher

England: SAGE Publications

More information

Scope and Contents

Contents

Crohn's disease (CD) involves immune system interactions with intestinal tissue, driven by pro-inflammatory cytokines like Tumor Necrosis Factor (TNF-α). Adalimumab, targeting TNF-α, regulates associated inflammatory responses. Despite being humanized, it may induce immunogenic processes, affecting treatment effectiveness. Thus, monitoring serum ad...

Alternative Titles

Full title

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11831650

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11831650

Other Identifiers

ISSN

0394-6320,2058-7384

E-ISSN

2058-7384

DOI

10.1177/03946320251319379

How to access this item